Zerlasiran showed very significant and durable reductions in lipoprotein(a) of up to 99% Lp(a) levels remained around 90% lower than baseline at study endpoint
News | Cardiovascular Clinical Studies
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease

November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to ...

Home November 10, 2023
Home
Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai.
News | Atrial Fibrillation
Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023

November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at ...

Home November 10, 2023
Home
DAIC Bivacor image
News | Artificial Heart
Total Artificial Heart Developer BiVACOR Mechanical Engineer Receives Sezai Innovation Award at ISMCS Annual Conference

November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has ...

Home November 10, 2023
Home
Further enhancing comprehensive trauma care solution
News | Artificial Intelligence
RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas

November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow solutions ...

Home November 09, 2023
Home
Clinical trial data released during VIVA 2023 Conference included results from a study involving the Veryan Medical BioMimics 3D Vascular Stent System.
News | VIVA
Final Round of Late-breaking Clinical Trial Results Announced at VIVA23

November 9, 2023 — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular ...

Home November 09, 2023
Home
The survey indicates the increased use of RPM to manage care both in clinics and home-based cardiac rehab settings
News | Remote Monitoring
New Cardiac Rehabilitation Survey Reveals 93% of Healthcare Providers Currently Utilize Remote Patient Monitoring Technology

November 9, 2023 — According to a recent survey of healthcare providers (HCPs), 93 percent of clinicians are currently ...

Home November 09, 2023
Home
DAIC MedInBox image
News | TCT
Medinbox Debuts New Digital Education Product Suites for Interventional Ecosystem

November 9, 2023 — Medinbox, a global provider of video integrated collaboration systems for interventional rooms and ...

Home November 09, 2023
Home
Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise Ultrasound Renal Denervation (RDN) system for the treatment of hypertension.
News | FDA
First FDA Approval of Renal Denervation System to Treat Hypertension Announced by Recor Medical and Otsuka Medical Devices

November 8, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U ...

Home November 08, 2023
Home
Agamon Health's Patient Adherence platform is aimed at raising standards of cardiovascular care
News | Artificial Intelligence
Agamon Health enters into know-how agreement with Mayo Clinic to close cardiology care gaps with generative AI

November 8, 2023 — Agamon Health is a healthcare technology company that uses Generative AI and workflow automation to ...

Home November 08, 2023
Home
The results come from a national study of more than 1 million U.S. hospital admissions among young adult tobacco users without other known cardiovascular risk factors
News | Stroke
Prediabetes and Persistent Tobacco Use May Triple Risk of Stroke in Healthy Young Adults

November 8, 2023 — The combination of persistent tobacco use and prediabetes (higher than normal blood sugar levels that ...

Home November 08, 2023
Home
Nova Heart creates a dynamic, 3D digital twin of a patient’s heart using 2D transthoracic echocardiogram data.
News | Artificial Intelligence
AIBODY Introduces Revolutionary Cardiology-centric 3D Digital Twinning Solution

November 8, 2023 — AIBODY, a leader in digital physiology solutions for healthcare, recently announced the release of ...

Home November 08, 2023
Home
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
News | FDA
Teleflex, and Arrow International, Recall Pressure Injectable Catheter Kits for Mislabeling

November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow ...

Home November 07, 2023
Home
New add-on code goes into effect Jan. 1, 2024
News | Catheter
Centers for Medicare and Medicaid Services Establishes New Category I CPT Add-On Code for Coronary IVL

November 7, 2023 — Shockwave Medical, Inc, a pioneer in the development and commercialization of transformational ...

Home November 07, 2023
Home
the first patients in the United States have been treated successfully utilizing Abbott’s EnSite X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System
News | Robotic Systems
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States

November 7, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home November 07, 2023
Home
Here's a look at what viewers found most interesting during the month of October on dicardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in October

As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home November 06, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now